Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA clears new AI software for mitral valve repair
Philips worked closely with Edwards Lifesciences to develop the new software.
World’s first telerobotic neurosurgery performed on stroke patient 120 miles away
Neurosurgeon Vitor Mendes Pereira, MD, was in Santiago, Panama, but his patient was in Panama City. "It is the highlight of my career to be involved in this historic achievement," Pereira said.
Premature menopause linked to substantial long-term heart risks
Starting menopause before the age of 40 could increase a woman's lifetime risk of coronary heart disease by up to 40%.
Cold weather responsible for many more stroke and heart attack deaths than heat
While heat consistently gets more attention in terms of public health messaging, new data show just how dangerous the cold can be.
Ransomware attack on UMMC causes 20% drop in revenue due to delayed patient care
The report on the financials comes from Mississippi Today. University of Mississippi Medical Center said it’s still processing paper backups and has extended clinic hours to address the backlog of elective surgeries and bring revenue back up to expectations. The attack happened in February and caused non-emergency operations at the health system to shut down for nine days.

Philips has secured U.S. Food and Drug Administration (FDA) clearance for EchoNavigator R5.0 with DeviceGuide, the company’s artificial intelligence (AI)-enabled software for mitral transcatheter edge-to-edge repair (M-TEER).

FDA clears new AI software for mitral valve repair

Philips worked closely with Edwards Lifesciences to develop the new software.

XCath Robotics, a Houston-based medical robotics company, announced the successful completion of the world’s first telerobotic stroke operation of its kind. Neurosurgeon Vitor Mendes Pereira, MD, chair of advanced neurovascular interventions at the University of Toronto, used the XCath Iris Surgical Robotic System to perform the historic procedure.

World’s first telerobotic neurosurgery performed on stroke patient 120 miles away

Neurosurgeon Vitor Mendes Pereira, MD, was in Santiago, Panama, but his patient was in Panama City. "It is the highlight of my career to be involved in this historic achievement," Pereira said.

Premature menopause linked to substantial long-term heart risks

Starting menopause before the age of 40 could increase a woman's lifetime risk of coronary heart disease by up to 40%.

Cold weather responsible for many more stroke and heart attack deaths than heat

While heat consistently gets more attention in terms of public health messaging, new data show just how dangerous the cold can be.

Ransomware attack on UMMC causes 20% drop in revenue due to delayed patient care

The report on the financials comes from Mississippi Today. University of Mississippi Medical Center said it’s still processing paper backups and has extended clinic hours to address the backlog of elective surgeries and bring revenue back up to expectations. The attack happened in February and caused non-emergency operations at the health system to shut down for nine days.

intrasaccular flow disruptor coronary aneurysm

Cardiologists use endovascular device for brain aneurysms to treat high-risk heart patients

A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.

When heart patients can’t wait: Urgent TAVR with self-expanding vs. balloon-expandable valves

The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities.

Cardiologist makes history with first commercial implant of new pacing lead for LBBAP

The first FDA-approved pacing lead specifically developed for LBBAP is now being implanted throughout the United States.